Photo of Michail Shafir

Michail Shafir

  • CLINICAL PROFESSOR Surgery, Surgical Oncology
  • CLINICAL PROFESSOR Oncological Sciences
Print ProfilePrint Profile

Certifications

  • American Board of Surgery

Education

  • MD, Universidad de Chile

  • Residency, Surgery
    Salvador Hospital

  • Residency, General Surgery
    La Pitie Hospital

  • Residency, Surgery/Oncology
    Gustave Roussy Cancer Institute

  • Residency, Surgery
    Mount Sinai Hospital

Biography

    Michail Shafir, M.D., is Clinical Professor of Surgery and the Ruttenberg Cancer Center and attending surgeon at The Mount Sinai Hospital.

    A graduate of the University of Chile and of the Surgery Residency program at Mount Sinai, he specializes in Surgical Oncology (for which he trained at the Gustave Roussy Cancer Institute in France). Dr. Shafir is a former President of the New York Cancer Society and a member of the Executive Council of the New York Surgical Society. He is a member of major surgical and cancer societies, such as the American College of Surgeons and the Society of Surgical Oncology, as well as a core member of the Surgery Committee of the CALGB, a major national cooperative group for clinical trials in cancer.

    An author of numerous scientific publications, his work has been presented at national and international conferences. Dr. Shafir's main clinical interests focus on surgery of breast tumors, malignant melanoma and neuroendocrine turmors. Dr. Shafir is fluent in French, Spanish, and Russian.

Research

Pharmacologic study

Phase I trial of intraperitoneal chemotherapy after hepatic dearterialization\r\nin liver malignancies.
    \r\n
  • Melanoma-carcinoid tumors
  • \r\n

Publications

Yeh HC, Shafir M, Meyer R, Cohen B, Geller S. Ultrasonography and computer tomography of pseudomyxoma peritonei. Radiology 1984; 153: 507-510.

Molt P, Shafir M, Aufses Jr AH. A unique surgical approach for massive retroperitoneal tumors. J Surg Oncol 1984; 26: 2-6.

Shafir M, Raventos E. Combined multimodality (Surgery, Radiotherapy, Intra arterial chemotherapy): Treatment of advanced carcinoma of paranasal sinuses. Recent Results in Cancer Research 1984; 86: 165-168.

Shafir M. Immune complexes in cancer and preneoplastic diseases. Mt Sinai J Med 1985; 52: 201-204.

Perlow L, Ohnuma T, Andrejuczuk A, Shafir M, Strauchen J, Holland JF. Pharmacology and Toxicology of a seven day infusion of 1 B D Arabinofuransylcystosine plus uridine in dogs. Cancer Research 1985; 45: 2572-2577.

Shafir M. What is cancer surgery. Mt Sinai J Med 1985; 52: 165-171.

Shafir M, Holland JF, Cohen B, Aufses Jr AH. Radical retroperitoneal tumor surgery with resection of the psoas major muscle. Cancer 1985; 56: 929-933.

Shafir M, Martinelli G, Bekesi JG, Jaramillo S, Heimann T, Holland JF, Aufses Jr AH. Immunoglobulins (Ig) in Circulating Immune Complexes (CIC) in cancer and Inflammatory Bowel Disease (IBD). Europ J Surg Oncol 1986; 12: 351-357.

Runowicz CD, Dottino PR, Shafir M, Mark M, Cohen CJ. Catheter complications associated with intraperitoneal chemotherapy. Gynecol Oncol 1986 May; 24(1): 41-50.

Bakare SC, Shafir M, McElhinney AJ. Exclusion of small bowel from pelvis for postoperative radiotherapy for rectal cancer. J Surg Oncol 1987; 35: 55-58.

Bakare SC, Shafir M, McElhinney AJ. Exclusion of small bowel from pelvis for postoperative radiotherapy for rectal cancer. J Surg Oncol 1987; 35: 55-58.

Jaramillo S, Shafir M, Bekesi G, Augses Jr AH. Circulating Immune Complexes (CIC) in cancer patients. Immunological Investigations 1987; 16(5): 383-398.

Shafir M, Jones R, Roboz J, Jaramillo S. Can colon cancer liver metastases be treated by high dose intraperitoneal 5 Fluorouracil. In: Kreidler J, Link KH, Aigner KR, editors. Advances in Regional Cancer Therapy. Ulm, Germany, III International Conference; 1988. pp100-104.

Greenstein AJ, Sachar BD, Shafir M, Rosenberg IR, Lewis C, Raju T, Szporn A, Janowitz H, Aufses Jr AH. Malignant Melanoma in Inflammatory Bowel Disease. Am J Gastroenterol 1992; 87(3): 317-320.

Shafir M. Surgical treatment of malignant melanoma : What's New and What's Not. Mt Sinai J Med 1992; 159(3): 217-219.

Shafir M. Modern management of malignant melanoma. Mt Sinai J Med 1992; 59(3): 192-193.

Eshkar NS, Shapiro RS, Shafir M, Sung M. Case Report: MRI of Extrapancreatic Gastrinoma. Computerized Medical Imaging and Graphics 1995; 19(5): 447-449.

Seijo L, Sidhu J, Mizrachy B, Shafir M, Tartter P, Bleiweiss IJ. Malignant Phyllodes Tumor of the Breast: A Report of Four Cases With Associated Fibroadenomata. Int J Surg Path 1995; 3(1): 17-22.

Shafir M, Shapiro R, Sung M, Warner R, Sicular A, Klipfel A. Cryoablation of Unresectable Malignant Liver Tumors. Amer J Surg 1996; 171: 27-31.

Shapiro RS, Shafir M, Sung M, Warner R, Glazehen N. Cryotherapy of Metastatic Carcinoid Tumors. Abdominal Imaging 1998; 23: 314-317.

Krynekyi BR, Kim CJ, Shafir MK, Mosci K, Macbac J. Breast Cancer and Its Management: The Utility and Technique of Lymphoscintigraphy. In: Leonard M, Freeman , Lippincott , Williams , Wilkins , editors. Nuclear Medicine Annual. 2003.

Krynekyi BR, Shafir MK, Kim SC, Kim DW, Travis A, Moadel RM, Kim CK. Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in cancer. International Seminars in Surgical Oncology 2005 November; 2(25).

Kim SC, Kim DW, Moadel RM, Kim CK, Chatterjee S, Shafir M, Travis A, Machac J, Krynekyi B. Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with high sensory morbidity following sentinel lymph node biopsy in breast cancer [review]. World J. Surg Onc 2005; 3(64).

Krynekyi BR, Shafir MK, Travis A, Kim CK. The Current State of the Art in Lymphoscintigraphy. Breast Diseases 2006 July-September; 17(2): 127-131.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Shafir is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

1060 5th Avenue
New York, NY 10128

Tel: 212-534-6900
Fax: 212-427-2193
Get Directions

Office Hours:
  • Monday 12:30pm - 5:00pm
  • Wednesday 2:00pm - 5:00pm
  • Thursday 2:00pm - 5:00pm
  • Friday 2:00pm - 5:00pm
Languages:
  • Spanish
  • Russian
  • French
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Personal Check
  • Cash